Science

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer

Nicholas van As/royalmarsden.nhs.uk

Dec 30, 2024, 12:25

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer

A recent paper by Nicholas van As, Medical Director of The Royal Marsden NHS Foundation Trust, was mentioned by Ioannis Goumas, Chief of Urology, Blessed Matteo Clinical Institute, San Donato Group, on X:

“I’m reading ‘At 2 years, 16/32 (50%) prostatectomy and three of 46 (6.5%) SBRT participants used one or more urinary pads daily (p < 0.001)’

And what about all the fancy outcomes of robotic Px?”

“Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial”

Authors: Nicholas van As, Binnaz Yasar, Clare Griffin, Stephanie Burnett, Emma Hall et al.

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer

Binnaz Yasar cancer Clare Griffin Emma Hall Ioannis Goumas Nicholas van As OncoDaily Oncology prostate cancer Radical Prostatectomy radiotherapy Stephanie Burnett

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Top 10 Immunotherapy Fellowships and Grants to Watch in 2025

July Is Sarcoma Awareness Month: What You Need to Know

Pat Soon-Shiong: SARS-CoV-2 Infection Can Awaken Sleeping Cancer Cells

Cary Adams' Keynote Message at Parliament House in Canberra - UICC